Alternative splicing regulation of telomerase: a new paradigm?

[1]  T. Cech,et al.  Inventory of telomerase components in human cells reveals multiple subpopulations of hTR and hTERT , 2014, Nucleic acids research.

[2]  I. Topisirovic,et al.  Inactive C-terminal telomerase reverse transcriptase insertion splicing variants are dominant-negative inhibitors of telomerase. , 2014, Biochimie.

[3]  J. Shay,et al.  Regulation of human telomerase splicing by RNA:RNA pairing , 2014, Nature Communications.

[4]  O. Podhajcer,et al.  The low‐abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer , 2014, International journal of cancer.

[5]  Jean-François Lucier,et al.  Tumor microenvironment–associated modifications of alternative splicing , 2014, RNA.

[6]  E. Blackburn,et al.  Molecular and Cellular Pathobiology The Major Reverse Transcriptase – Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis , 2013 .

[7]  J. Shay,et al.  Regulation of telomerase alternative splicing: a target for chemotherapy. , 2013, Cell reports.

[8]  A. Krainer,et al.  Pick one, but be quick: 5' splice sites and the problems of too many choices. , 2013, Genes & development.

[9]  C. Milcarek,et al.  Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms , 2013, Cancer Immunology, Immunotherapy.

[10]  J. Valcárcel,et al.  The spliceosome as a target of novel antitumour drugs , 2012, Nature Reviews Drug Discovery.

[11]  R. Hrdličková,et al.  Alternatively Spliced Telomerase Reverse Transcriptase Variants Lacking Telomerase Activity Stimulate Cell Proliferation , 2012, Molecular and Cellular Biology.

[12]  R. Padgett.  New connections between splicing and human disease. , 2012, Trends in genetics : TIG.

[13]  Dmitri D. Pervouchine,et al.  conserved long-range RNA structures Evidence for widespread association of mammalian splicing and Material Supplemental , 2011 .

[14]  M. Hagiwara,et al.  Stress-responsive maturation of Clk1/4 pre-mRNAs promotes phosphorylation of SR splicing factor , 2011, The Journal of cell biology.

[15]  M. Pagel,et al.  Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination , 2011, Aging cell.

[16]  D. Auboeuf,et al.  Real-time imaging of cotranscriptional splicing reveals a kinetic model that reduces noise: implications for alternative splicing regulation , 2011, The Journal of cell biology.

[17]  B. Graveley.  The developmental transcriptome of Drosophila melanogaster , 2010, Nature.

[18]  F. Döring,et al.  Specific regulation of low-abundance transcript variants encoding human Acyl-CoA binding protein (ACBP) isoforms , 2010, Journal of cellular and molecular medicine.

[19]  Matthieu Legendre,et al.  Variable tandem repeats accelerate evolution of coding and regulatory sequences. , 2010, Annual review of genetics.

[20]  P. Rudland,et al.  Microarray Analysis of Suppression Subtracted Hybridisation Libraries Identifies Genes Associated with Breast Cancer Progression , 2010, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[21]  T. Nilsen,et al.  Expansion of the eukaryotic proteome by alternative splicing , 2010, Nature.

[22]  J. Pritchard,et al.  Characterizing natural variation using next-generation sequencing technologies. , 2009, Trends in genetics : TIG.

[23]  Timothy D. Veenstra,et al.  Telomerase modulates Wnt signalling by association with target gene chromatin , 2009, Nature.

[24]  Gene W. Yeo,et al.  An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells , 2009, Nature Structural &Molecular Biology.

[25]  Sandrine Dudoit,et al.  Novel Low Abundance and Transient RNAs in Yeast Revealed by Tiling Microarrays and Ultra High–Throughput Sequencing Are Not Conserved Across Closely Related Yeast Species , 2008, PLoS genetics.

[26]  Wilhelm Palm,et al.  How shelterin protects mammalian telomeres. , 2008, Annual review of genetics.

[27]  J. Eshleman,et al.  Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms. , 2008, Thyroid : official journal of the American Thyroid Association.

[28]  Kai-Wei Chang,et al.  RNA-binding proteins in human genetic disease. , 2008, Trends in genetics : TIG.

[29]  William Ritchie,et al.  Entropy Measures Quantify Global Splicing Disorders in Cancer , 2008, PLoS Comput. Biol..

[30]  Gil Ast,et al.  Alternative splicing and disease , 2008, RNA biology.

[31]  K. Hui,et al.  Identification of unique and common low abundance tumour-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis , 2007, Oncogene.

[32]  Gil Ast,et al.  Insights into the connection between cancer and alternative splicing. , 2008, Trends in genetics : TIG.

[33]  Guey-Shin Wang,et al.  Splicing in disease: disruption of the splicing code and the decoding machinery , 2007, Nature Reviews Genetics.

[34]  N. Bache,et al.  Protein Composition of Catalytically Active Human Telomerase from Immortal Cells , 2007, Science.

[35]  Michael Q. Zhang,et al.  Pan‐genome isolation of low abundance transcripts using SAGE tag , 2006, FEBS letters.

[36]  C. Maley,et al.  Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .

[37]  G. Gaudernack,et al.  Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues , 2006, BMC Molecular Biology.

[38]  B. Blencowe.  Alternative Splicing: New Insights from Global Analyses , 2006, Cell.

[39]  A. Kornblihtt,et al.  The connection between splicing and cancer , 2006, Journal of Cell Science.

[40]  J. Venables.  Unbalanced alternative splicing and its significance in cancer , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[41]  B. Graveley.  Coordinated control of splicing and translation , 2005, Nature Structural &Molecular Biology.

[42]  Brenton R Graveley,et al.  Mutually Exclusive Splicing of the Insect Dscam Pre-mRNA Directed by Competing Intronic RNA Secondary Structures , 2005, Cell.

[43]  M. Moore.  From Birth to Death: The Complex Lives of Eukaryotic mRNAs , 2005, Science.

[44]  Jian Wang,et al.  Detecting novel low-abundant transcripts in Drosophila. , 2005, RNA.

[45]  L. Latonen,et al.  hTERT antagonizes p53-induced apoptosis independently of telomerase activity , 2005, Oncogene.

[46]  R. Moyzis,et al.  Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma , 1999, Breast Cancer Research and Treatment.

[47]  Melissa S Jurica,et al.  Pre-mRNA splicing: awash in a sea of proteins. , 2003, Molecular cell.

[48]  Christopher J. Lee,et al.  Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss , 2003, Nature Genetics.

[49]  M. Fukuda.  Roles of mucin-type O-glycans in cell adhesion. , 2002, Biochimica et biophysica acta.

[50]  N. Zaffaroni,et al.  Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity , 2002, The Journal of pathology.

[51]  Jun-Ping Liu,et al.  TERT regulates cell survival independent of telomerase enzymatic activity , 2002, Oncogene.

[52]  J. Klein,et al.  Bioessays news and reviews in molecular, cellular and developmental biology , 2002 .

[53]  J. Shay,et al.  Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. , 2001, Nucleic acids research.

[54]  M. Garcia-Blanco,et al.  Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. , 2001, Gene.

[55]  J. Griffith,et al.  T‐loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang , 2001, The EMBO journal.

[56]  E. Blackburn.  Switching and Signaling at the Telomere , 2001, Cell.

[57]  L. Giudice,et al.  Tissue‐specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development , 2001, International journal of cancer.

[58]  J. Shay,et al.  Telomerase inhibitors. , 2001, Trends in biotechnology.

[59]  Piero Carninci,et al.  Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes. , 2000, Genome research.

[60]  A. Kilian,et al.  The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. , 2000, Neoplasia.

[61]  J. Shay,et al.  An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. , 2000, Neoplasia.

[62]  R. Insel,et al.  Up‐regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase catalytic subunit , 1999, European journal of immunology.

[63]  D. Bowtell,et al.  Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. , 1997, Human molecular genetics.

[64]  R. Reddel.  Telomerase and cancer. , 1997, Japanese journal of cancer research : Gann.

[65]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[66]  Aaron P. Campbell,et al.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[67]  J. Shay,et al.  Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. , 1996, The EMBO journal.

[68]  J. Shay,et al.  The reactivation of telomerase activity in cancer progression. , 1996, Trends in genetics : TIG.

[69]  J. Shay,et al.  Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.

[70]  H. Klamut,et al.  The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced , 1995, Nature Genetics.

[71]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[72]  M. Ligtenberg,et al.  Cell membrane-associated mucins and their adhesion-modulating property. , 1992, Trends in biochemical sciences.

[73]  C B Harley,et al.  Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.

[74]  C B Harley,et al.  Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.

[75]  C. Greider.  Telomeres, telomerase and senescence , 1990, BioEssays : news and reviews in molecular, cellular and developmental biology.

[76]  Y. Osheim,et al.  Splice site selection, rate of splicing, and alternative splicing on nascent transcripts. , 1988, Genes & development.

[77]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[78]  A M Olovnikov,et al.  A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. , 1973, Journal of theoretical biology.